Jasper Therapeutics grants options to director
Jasper Therapeutics, Inc. reported that director Thomas G. Wiggans received an automatic grant of a stock option covering 7,500 shares of Voting Common Stock at an exercise price of $0.6300 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Jasper Therapeutics, Inc. reported that director Thomas G. Wiggans received an automatic grant of a stock option covering 7,500 shares of Voting Common Stock at an exercise price of $0.6300 per share. The option expires on 2036-07-31 and, under the Non-Employee Director Compensation Policy, vests in full on the first anniversary of the 2026-07-31 grant date, subject to his continued board service.
Insider Trade Summary
Grant/Award: 7,500 shares
Grant/Award
1 txn
Insider
WIGGANS THOMAS G
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy F1 | 7,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy — 7,500 contracts (Direct)
Footnotes (1)
- F1. Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.
Key Figures
Option Shares Granted: 7500.0000 shares
Exercise Price: 0.6300 per share
Total Derivative Shares After Grant: 7500.0000 shares
+3 more
6 metrics
Option Shares Granted
7500.0000 shares
Stock option covering Voting Common Stock granted to director on 2026-07-31
Exercise Price
0.6300 per share
Conversion or exercise price of the stock option
Total Derivative Shares After Grant
7500.0000 shares
Director’s total stock option holdings following this transaction
Option Expiration Date
2036-07-31
Expiration date of the granted stock option
Grant Date
2026-07-31
Date on which the non-employee director option was granted
Vesting Anniversary
1 year
Option vests in full upon first anniversary of grant, subject to continued service
Key Terms
Non-Employee Director Compensation Policy, stock option, vesting, exercise price
4 terms
Non-Employee Director Compensation Policy financial
"Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy"
stock option financial
"non-employee directors are automatically granted an option to purchase 7,500 shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"which shall vest in full upon the first anniversary of the date of the grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price of 0.6300 per share for the stock option"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did JSPR director Thomas G. Wiggans report?
Thomas G. Wiggans reported a grant of stock options for 7,500 shares of Jasper Therapeutics Voting Common Stock at an exercise price of $0.6300 per share, received as part of the Non-Employee Director Compensation Policy.
What are the key terms of Thomas G. Wiggans’ new JSPR stock options?
The option covers 7,500 shares of Voting Common Stock with a $0.6300 exercise price, was granted on 2026-07-31, becomes exercisable after one year of service, and expires on 2036-07-31.
How and when do Thomas G. Wiggans’ JSPR options vest?
The stock option vests in full on the first anniversary of the 2026-07-31 grant date, subject to Wiggans’ continued service as a non-employee director through that vesting date under the company’s policy.
Is the JSPR option grant to Thomas G. Wiggans a market purchase?
No. The transaction is a grant/award acquisition of a stock option with a $0.0000 transaction price per share, made automatically under Jasper Therapeutics’ Non-Employee Director Compensation Policy, not an open-market purchase.
How many derivative securities does Thomas G. Wiggans directly hold after this JSPR grant?
Following this reported transaction, Wiggans directly holds 7,500.0000 stock option derivatives related to Jasper Therapeutics’ Voting Common Stock, all from this single option grant reported in the Form 4 data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates